Dr. Aditya Bardia, MD, MPH
Claim this profileMassachusetts General Hospital
Expert in Breast Cancer
Studies Breast cancer
15 reported clinical trials
33 drugs studied
Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
2Breast Cancer
HER2 negative
HER2
ER negative
Affiliated Hospitals
Clinical Trials Aditya Bardia, MD, MPH is currently running
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting1 award Phase 12 criteria
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial in participants with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the recommended Phase 2 dose (RP2D) of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, capivasertib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations.
Recruiting1 award Phase 1 & 2
More about Aditya Bardia, MD, MPH
Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Aditya Bardia, MD, MPH has experience with
- Fulvestrant
- Alpelisib
- Palbociclib
- Ribociclib
- Everolimus
- Sacituzumab Govitecan
Breakdown of trials Aditya Bardia, MD, MPH has run
Breast Cancer
Breast cancer
Endometrial Cancer
No disease or condition mentioned.
Fibroblast Growth Factor Receptor 1 High Amplification
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aditya Bardia, MD, MPH specialize in?
Aditya Bardia, MD, MPH focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage IV.
Is Aditya Bardia, MD, MPH currently recruiting for clinical trials?
Yes, Aditya Bardia, MD, MPH is currently recruiting for 8 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Aditya Bardia, MD, MPH has studied deeply?
Yes, Aditya Bardia, MD, MPH has studied treatments such as Fulvestrant, Alpelisib, Palbociclib.
What is the best way to schedule an appointment with Aditya Bardia, MD, MPH?
Apply for one of the trials that Aditya Bardia, MD, MPH is conducting.
What is the office address of Aditya Bardia, MD, MPH?
The office of Aditya Bardia, MD, MPH is located at: Massachusetts General Hospital, Boston, Massachusetts 02114 United States. This is the address for their practice at the Massachusetts General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.